Shaheen Mahira

Dr. Shaheen Mahira

University of Pittsburgh, Pittsburgh, Pennsylvania, USA
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SMShaheen Mahira
Shaheen Mahira
Nagavendra KommineniNagavendra Kommineni
Nagavendra Kommineni
GHGulam Mohammed Husain
Gulam Mohammed Husain
WKwahid khan
wahid khan
Cancer stem cells (CSCs) are the promising targets for cancer chemotherapy that cannot be eliminated by conventional chemotherapy. In this study cationic liposomes of cabazitaxel (CBX) and silibinin (SIL) were prepared with an aim to kill cancer cells and CSCs for prostate cancer. CBX act as cancer cell inhibitor and SIL as CSC inhibitor. Hyaluronic acid (HA), an endogenous anionic polysaccharide was coated on cationic liposomes for targeting CD44 receptors over expressed on CSCs. Liposomes were prepared by ethanol injection method with particle size below 100 nm and entrapment efficiency of more than 90% at 10% w/w drug loading. Liposomes were characterized by dynamic light scattering, transmission electron microscopy, 1H nuclear magnetic resonance and scanning electron microscopy-energy dispersive x-ray spectroscopy. Liposomes were evaluated for their anticancer action in androgen independent human prostate cancer cell lines (PC-3 and DU-145). HA coated liposomes showed potential cytotoxicity over other groups with low IC50, significantly inhibited cell migration and induced apoptosis. Synergistic cytotoxic effect was also observed with HA coated liposomes that resulted in colony formation inhibition and G2/M phase arrest. Proficient cytotoxicity against CD44+ cells (14.87 ± 0.41% in PC-3 and 33.95 ± 0.68% in DU-145 cells) indicated the efficiency of HA coated liposomes towards CSC targeting. Hence, the outcome of this combinational therapy with CD44 targeting indicates the suitability of HA coated CBX and SIL co-loaded liposomes as a potential approach for eradicating prostate cancer and herein might provide a insight for future studies.

1 September 2017 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
SDSindhu Doppalapudi
Sindhu Doppalapudi
SMShaheen Mahira
Shaheen Mahira
WKwahid khan
wahid khan

25 March 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Nagavendra KommineniNagavendra Kommineni
Nagavendra Kommineni
SMShaheen Mahira
Shaheen Mahira
Avi J. DombAvi J. Domb
Avi J. Domb
WKwahid khan
wahid khan
Jevtana® is a micellar cabazitaxel (CBZ) solution that was approved for prostate cancer in 2010, and recently, this drug has been reported for breast cancer. The purpose of this study is to evaluate the mediated delivery of CBZ via liposomes and nanoparticles (NPs) for the treatment of breast cancer and compare these with a micellar formulation that is currently in clinical use. CBZ-loaded nanocarriers were prepared with particle sizes between 70–110 nm, and with the sustained in vitro release of CBZ for more than 28 days. Cytotoxicity studies on MCF-7 and MDA-MB-231 cells demonstrated the toxic potential of these nanocarriers. Cellular internalization revealed that NPs and liposomes have better permeability than micelles. Cell cycle analysis and apoptosis studies on MCF-7 and MDA-MB-231 cells confirmed G2/M phase arrest as well as cell death due to apoptosis and necrosis, where formulations were found to be effective compared to a micellar CBZ solution. Results from pharmacokinetic studies revealed that there is an increased circulation half-life and mean residence time for CBZ liposomes and NPs in comparison with a micellar CBZ solution. CBZ liposomes and NPs showed a reduction in hemolysis and neutropenia in comparison with a micellar CBZ solution in rats.

31 July 2019
Verified
Book Chapter
Closed access
PDF file
SMShaheen Mahira
Shaheen Mahira
AJAnjali Jain
Anjali Jain
WKWahid Khan
Wahid Khan
ADAbraham J. Domb
Abraham J. Domb
Infectious disease management has become an increasing challenge in recent years. According to the Centers for Disease Control and Prevention and the World Health Organization, microbial infections are a top concern. Pathogenic microorganisms are of main concern in hospitals and other healthcare locations, as they affect the optimal functioning of medical devices, surgical devices, bone cements, etc. Combatting microbial infections has become a serious health concern and major challenging issue due to antimicrobial resistance or multidrug resistance and has become an important research field in science and medicine. Antibiotic resistance is a phenomenon where microorganisms acquire or innately possess resistance to antimicrobial agents. New materials offer a promising antimicrobial strategy as they can kill or inhibit microbial growth on their surface or within the surrounding environment with superior efficacy, low toxicity and minimized environmental problems. The present chapter focuses on classification of antimicrobial materials, surface modification and design requirements, their mode of action, antimicrobial evaluation tests and clinical status.

22 April 2019 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Open access
PDF file
AJAnjali Jain
Anjali Jain
SMShaheen Mahira
Shaheen Mahira
JMJean‐Pierre Majoral
Jean‐Pierre Majoral
MBMaria Bryszewska
Maria Bryszewska
WKwahid khan
wahid khan
Maksim IonovMaksim Ionov
Maksim Ionov
Irresponsiveness of triple negative breast cancer (TNBC) toward conventional therapies has drawn attention toward siRNA therapeutics. In gene delivery, dendrimers are gaining significant attention due to their characteristic features and polo‐like kinase (PLK1) is reported as a potential target for TNBC. In this work, phosphorus and polyamidoamine dendrimer (generation 3 and 4 of each type) are explored to address delivery challenges of PLK1 siRNA (siPLK1). Dendriplexes were formed and complexation was found at 3:1 N/P ratio for all dendrimers by gel electrophoresis. Complexation was also supported by zeta potential, circular dichroism and intercalation assay. Dendriplexes were found to be stable in presence of ribonuclease and serum. Dendriplexes resulted in enhanced cell uptake of siPLK1 compared to siPLK1 solution in MDA‐MB‐231 and MCF‐7 cells. Dendriplexes caused increased cell arrest in sub‐G1 phase compared to solution. These observations suggested phosphorus and polyamidoamine dendrimers as potential carriers for siPLK1 delivery to treat TNBC.

1 August 2019 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SMShaheen Mahira
Shaheen Mahira
Nagavendra KommineniNagavendra Kommineni
Nagavendra Kommineni
SDSindhu Doppalapudi
Sindhu Doppalapudi
WKwahid khan
wahid khan